Skip to Content

Zostavax Sales Data

Rank 87 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Zostavax U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 87 (12) 15.17% 20.53%
Q3 2013 99 ()
Q4 2012 70 (14) 14.39% 10.95%
Q3 2012 84 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

October 26, 2017Expert Panel Recommends New Shingles Vaccine, Shingrix, as First-Line Treatment
October 26, 2017There's a New Shingles Vaccine, Shingrix, -- Is It for You?
October 26, 2017Health Highlights: Oct. 26, 2017
October 23, 2017Health Highlights: Oct. 23, 2017
September 14, 2016Experimental Shingles Vaccine Looks Quite Effective: Study
December 31, 2015Asthma May Be Linked to Shingles Risk
December 15, 2015Shingles Linked to Raised Heart Risks for Seniors, Study Finds
October 5, 2011Health Tip: Getting the Shingles Vaccine
March 24, 2011U.S. Shingles Vaccine Approval Expanded
January 12, 2011Shingles Vaccine Associated With 55 Percent Reduced Risk of Disease
January 12, 2011Vaccine For Shingles Ailment Effective -- And Seldom Used, Study Says
January 11, 2011Shingles Vaccine Looks Like a Safe Bet for Seniors: Study
May 14, 2010New Large Study Results Confirm Safety Profile of Zostavax, Merck's Shingles Vaccine, in People Aged 60 or Older
February 8, 2010Getting Shingles Vaccine Easier